The authors reply:

Michael S. Burnim, Kunbo Wang, William Checkley, Eric P. Nolley, Yanxun Xu, Brian T. Garibaldi

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)E592-E594
JournalCritical care medicine
Volume50
Issue number6
DOIs
StatePublished - Jun 1 2022

Funding

Dr. Garibaldi received funding from Janssen Research and Development, Gilead Life Sciences, and Atea Pharmaceuticals. The remaining authors have disclosed that they do not have any potential conflicts of interest.

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this